- Home
- IDXX
as 08-01-2025 4:00pm EST
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 35% of its revenue from outside the United States.
Upcoming Earnings Alert:
Get ready for potential market movements as IDEXX Laboratories Inc. IDXX prepares to release earnings report on 04 Aug 2025.
| Founded: | 1983 | Country: | United States |
| Employees: | N/A | City: | WESTBROOK |
| Market Cap: | 42.7B | IPO Year: | 1991 |
| Target Price: | $544.75 | AVG Volume (30 days): | 543.6K |
| Analyst Decision: | Buy | Number of Analysts: | 8 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 10.82 | EPS Growth: | 4.80 |
| 52 Week Low/High: | $356.14 - $579.47 | Next Earning Date: | 08-04-2025 |
| Revenue: | $3,931,836,000 | Revenue Growth: | 5.56% |
| Revenue Growth (this year): | 8.38% | Revenue Growth (next year): | 7.69% |
Stock Insider Trading Activity of IDEXX Laboratories Inc. (IDXX)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| SZOSTAK M ANNE | IDXX | Director | May 21 '25 | Sell | $513.04 | 2,306 | $1,182,916.79 | 262 | |
| JUNIUS DANIEL M | IDXX | Director | May 13 '25 | Sell | $506.41 | 2,683 | $1,358,697.23 | 3,304 | |
| Vandebroek Sophie V. | IDXX | Director | May 9 '25 | Sell | $491.34 | 1,279 | $628,425.27 | 1,167 |
Latest IDEXX Laboratories Inc. News
IDXX Breaking Stock News: Dive into IDXX Ticker-Specific Updates for Smart Investing
Insider Monkey
2 months ago
IDEXX Laboratories (IDXX) Price Target Hiked to $580 at Leerink Partners
Simply Wall St.
2 months ago
Investing in IDEXX Laboratories (NASDAQ:IDXX) five years ago would have delivered you a 66% gain
MT Newswires
2 months ago
Leerink Partners Adjusts IDEXX Laboratories Price Target to $580 From $515
Simply Wall St.
2 months ago
IDEXX Laboratories (NasdaqGS:IDXX) Launches Catalyst Cortisol Test for Canine Health
CNW Group
2 months ago
Third Expansion of IDEXX's Catalyst Platform in Under a Year Delivers Critical Insights to Veterinarians Evaluating Canine Patients for Endocrine Disorders
Argus Research
2 months ago
IDXX: Rating increased to a BUY
Zacks
2 months ago
If You Invested $1000 in Idexx Laboratories a Decade Ago, This is How Much It'd Be Worth Now
MT Newswires
2 months ago
Stifel Adjusts Price Target on IDEXX Laboratories to $510 From $460, Maintains Hold Rating
Compare IDXX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "IDXX IDEXX Laboratories Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.